The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
about
Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its Clinical ImplicationsPaucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndromeVirulence-Associated Enzymes of Cryptococcus neoformansElucidating the immunological function of the Cryptococcus neoformans capsuleA Single Protein S-acyl Transferase Acts through Diverse Substrates to Determine Cryptococcal Morphology, Stress Tolerance, and Pathogenic OutcomeCryptococcal interactions with the host immune system.Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan.Differential virulence of Candida glabrata glycosylation mutantsCharacterization of the PMT gene family in Cryptococcus neoformans.Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.Innate recognition of fungal cell wallsHow sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.KRE genes are required for beta-1,6-glucan synthesis, maintenance of capsule architecture and cell wall protein anchoring in Cryptococcus neoformansFungal vaccines and immunotherapeutics.Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses.Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes via conserved epitopes.Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis.Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans.Exploiting fungal cell wall components in vaccinesUnraveling the novel structure and biosynthetic pathway of O-linked glycans in the Golgi apparatus of the human pathogenic yeast Cryptococcus neoformans.Multiple Disguises for the Same Party: The Concepts of Morphogenesis and Phenotypic Variations in Cryptococcus neoformansParadoxical Immune Responses in Non-HIV Cryptococcal MeningitisFungal Inositol Pyrophosphate IP7 Is Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity.A glycosylphosphatidylinositol anchor is required for membrane localization but dispensable for cell wall association of chitin deacetylase 2 in Cryptococcus neoformans.Unraveling unique structure and biosynthesis pathway of N-linked glycans in human fungal pathogen Cryptococcus neoformans by glycomics analysis.Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccinesVaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.Integrated Activity and Genetic Profiling of Secreted Peptidases in Cryptococcus neoformans Reveals an Aspartyl Peptidase Required for Low pH Survival and Virulence.An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan StructureThe role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans).Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotidesThe Mannoprotein Cig1 supports iron acquisition from heme and virulence in the pathogenic fungus Cryptococcus neoformans.Role of the mannose receptor in a murine model of Cryptococcus neoformans infectionSynthesis of cell envelope glycoproteins of Cryptococcus laurentii.A Candida albicans mannoprotein deprived of its mannan moiety is efficiently taken up and processed by human dendritic cells and induces T-cell activation without stimulating proinflammatory cytokine productionThe phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis.Mannose Receptor Is Required for Optimal Induction of Vaccine-Induced T-Helper Type 17 Cells and Resistance to Blastomyces dermatitidis Infection.Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
P2860
Q24629367-A930DB1B-FCFE-4BE7-8DBD-610D39008A01Q24630287-FAD886A9-C128-4223-8215-F33B6594A28BQ26785005-BAB00020-D047-4072-AD73-47A1BBB52354Q26859234-0D213147-97EA-4108-8891-3198BF9E3D88Q27319842-B4240B51-81D2-4513-834C-F0826EBBAC6EQ30387948-3597779B-8677-4AEF-A31E-D4DF8878E680Q30481655-3686BD9D-46EE-43EC-8458-330D85FF9505Q30541824-367AA755-BD40-4B1A-AD5F-6910E8039ABCQ33487159-6DAF2FB1-B4D6-4BE1-A001-B37FCB14DA54Q33522882-C9429F6A-D0F8-4770-B696-29CBF7321E47Q33565418-197CAB41-DCB0-4242-A228-048E2021039EQ33894565-E589E364-B369-415B-9B98-F311C8DB8A86Q34265597-C8201A2B-311B-4F2A-A57B-81FA49CCB5C2Q34400249-0D8421AA-8D75-48EE-B72E-A876D6F295AAQ34447658-12D1D49A-DBD8-45AB-A572-F1EB470E1EEAQ34468247-5CE397CF-723E-4C66-8A07-FD50B3A67B6DQ34594241-EEA234B5-B17D-4D77-B1E0-3C52A16E323CQ34775729-87A50479-9B63-4F4B-AA3B-594EA3CFAAADQ35085200-C1A259F2-AA56-4F71-A250-D2805513B724Q35121366-D6DEE1E8-AC73-499E-9155-2637852D6793Q35197055-079CB4F5-790D-4C3B-9720-9080A6F0A929Q35645083-A50944C6-00F8-4D90-A34C-716B8697AFE1Q35676308-4322218A-6FD0-420F-9FE9-F0D7E51A2457Q35759756-52430440-83A2-496B-88BC-AA7E25755EE5Q36003854-99B12CA2-A2B7-4903-A6E7-93E72A121960Q36026319-274FEC5D-0836-4BAB-9DA1-DEE38C5C64C4Q36192774-FAC6AA72-AC18-4441-A4A1-F3499277A481Q36225321-CA2D910C-36D0-40A0-9C45-B4D503458061Q36313815-08C1F777-D37E-454A-89EE-25488761DBA5Q36431583-6265E272-AEA7-4498-88F7-A10F512C5A6BQ36431950-FD373B3D-DC12-45D7-A572-537506FC7052Q36535793-166180A5-9E9F-4197-9A9B-B38D011D73D0Q36544402-4495EF16-8B82-44F4-96ED-4BB926D2F1E6Q36702623-F660F41A-8455-4BA1-8BCF-82C3DA6E4422Q36710580-77F815C8-F930-4927-BCD0-005E4F330C4AQ36742785-1F71617A-D117-4505-A202-36C38AA86A9DQ36845263-1A9F69EB-0F0D-4ABF-A7A5-EABAC31F3B9FQ36846260-D7234A9E-188F-4012-961F-78698342071EQ36871928-927F0373-B501-4E8C-8CA3-C0C1B23A3A98Q37051210-AD9D6D19-122D-44BA-AED2-97C7950D9148
P2860
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
@ast
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
@en
type
label
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
@ast
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
@en
prefLabel
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
@ast
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
@en
P1433
P1476
The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins.
@en
P2093
Charles A Specht
Stuart M Levitz
P304
P356
10.1111/J.1567-1364.2006.00071.X
P577
2006-06-01T00:00:00Z